Volkow ND

National Institute on Drug Abuse, National Institutes of Health, Bethesda, MD, US.

3 papers · 1 preprint · ORCID

ArticlePsychedelics

Polysubstance use disorders among US adults.

Han B, Volkow ND, Jones CM +7

Europe PMC2026
ArticlePsilocybin

Single-dose psilocybin therapy for alcohol use disorder: Pharmacokinetics, feasibility, safety and efficacy in an open-label study.

Jensen ME, Stenbæk DS, Messell CD +8

Europe PMC2025
PreprintPsilocybin

­­­­Single-Dose Psilocybin Therapy for Alcohol Use Disorder: Pharmacokinetics, Feasibility, Safety, and Efficacy in an Open-Label Study

Jensen ME, Stenbæk DS, Messell CD +8

Europe PMC2024
ArticleKetamine

No time to lose: the current state of research in rapid-acting psychotherapeutics.

Gordon JA, Volkow ND, Koob GF

Europe PMC2024